Table of Content

1          Target Background

2          Target Antigen Expression Profile

3          Preclinical Proof-of-Concept

4          Clinical Indications & Patient Populations

5          Competitive Landscape & Drug Modalities

6          Drug & Cell Therapy Candidate Profiles

6.1       CAR T-Cells

6.2       Pro-Apoptotic Bispecific Antibodies

6.3       T-Cell Redirecting Bispecific Antibodies

6.4       Naked Antibodies

7          Company Profiles

8          References